Ranitidine
Back to searchMolecule Structure
Scientific Name
Ranitidine
Description of the Drug
Ranitidine is a histamine H2 antagonist used to treat duodenal ulcers, Zollinger-Ellison syndrome, gastric ulcers, GERD, and erosive esophagitis.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00863
http://www.drugbank.ca/drugs/DB00863
Brand Name(s)
Not Available
Company Owner(s)
Boehringer Ingelheim Corp, Glaxosmithkline, Ranbaxy Pharmaceuticals Inc, Watson Laboratories Inc, Actavis Mid Atlantic Llc, Taro Pharmaceuticals Usa Inc, Mylan Pharmaceuticals Inc, Zydus Pharmaceuticals Usa Inc, Novitium Pharma Llc, Akorn Operating Co Llc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Histamine H2 receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL1941 |
Clinical Trial(s)
Unichem Links
| Atlas | ranitidine | |||
| Human Metabolome Database | HMDB0259516 | |||
| DrugBank | DB00863 | |||
| PubChem | 5039 | |||
| Mcule | MCULE-2682233624 | |||
| LINCS | LSM-2298 | |||
| EPA CompTox Dashboard | DTXSID8045191 | |||
| DrugCentral | 2358 | |||
| rxnorm | RANITIDINE HYDROCHLORIDE | RANITIDINE | ZANTAC | RANITIDINE BISMUTH CITRATE |
| ChEBI | 92246 |
